查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842339

全球甲状腺癌诊断市场：市场规模、份额、趋势分析（按癌症类型、技术、最终用途和地区划分）、细分市场预测（2025-2033 年）

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Cancer Type (Papillary Carcinoma, Follicular Carcinoma), By Technique (Imaging, Biopsy), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

甲状腺癌诊断：市场概览

全球甲状腺癌诊断市场预计在 2024 年达到 30.7 亿美元，预计到 2033 年将达到 50.3 亿美元，2025 年至 2033 年的复合年增长率为 5.86%。

这一增长归因于甲状腺癌发病率的上升、人们对早期筛检计画的认识不断提高，以及影像方式和分子检测等诊断工具的重大技术进步。

此外，医疗保健支出不断增长、有利的报销政策以及向个人化医疗的转变也是推动市场扩张的部分因素。此外，人口老化、医疗基础设施的改善以及持续的研发投入也进一步推动了市场扩张，从而能够早期、准确地检测和治疗甲状腺癌。

甲状腺癌诊断涵盖一系列广泛的检测和程序，包括影像学检查、切片检查、血液检查和分子谱分析，用于检测和表征甲状腺癌，并指南临床决策和个人化治疗。由于甲状腺癌患者数量的不断增加，全球甲状腺癌诊断市场正在迅速扩张。患者数量的增长推动了对早期检测和有效筛检工具的需求，医疗机构优先考虑主动识别以改善预后。根据美国癌症协会预测，2025年美国预计将新增约44,020例甲状腺癌病例，其中约31,350例为女性，约12,670例为男性。甲状腺癌在女性中更为常见，通常在比许多其他癌症更年轻时被诊断出来。

技术进步是推动该市场发展的主要动力。例如，2024年5月，GE医疗推出了Revolution RT，这是一款先进的放射治疗电脑断层扫描（CT）解决方案。此创新系统旨在提高影像精度、简化模拟工作流程，并支援更个人化和无缝的肿瘤治疗。 Revolution RT融合了人工智慧主导技术和现代化的软体平台，使临床医生能够实现精准的肿瘤靶向和更高效的治疗方案。

此外，远端医疗和数位健康平台的普及进一步扩大了甲状腺癌诊断的覆盖范围，尤其惠及偏远和医疗资源匮乏地区的居民。透过远距会诊，患者可以获得早期筛检建议和后续治疗，确保及时干预，不受地理限制。

此外，遗传风险因素基因检测的日益普及也为市场创造了新的机会。先进的基因组检测可以识别与甲状腺肿瘤相关的突变，有助于更精准的诊断和个人化的治疗策略。甲状腺癌发病率的上升、Revolution RT等最尖端科技的出现、个人化医疗的兴起、数位医疗的普及以及基因检测的扩展——这些因素共同推动了甲状腺癌诊断行业的强劲增长，从而实现更早期的检测和更优质的患者照护。

目录

第一章 分析方法和范围

第二章执行摘要

3. 全球甲状腺癌诊断市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 甲状腺癌诊断市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第四章 全球甲状腺癌诊断市场：按癌症类型分類的商业分析

  • 癌症类型仪錶板
  • 甲状腺癌诊断市场：按癌症类型分類的波动分析
  • 全球甲状腺癌诊断市场规模及趋势分析（按癌症类型划分）（2021-2033 年）
  • 乳头状癌
  • 滤泡癌
  • 其他的

5. 全球甲状腺癌诊断市场：按技术分類的业务分析

  • 技术专用仪錶板
  • 甲状腺癌诊断市场：依技术分類的差异分析
  • 全球甲状腺癌诊断市场规模及技术趋势分析（2021-2033）
  • 血液检查
  • 影像诊断
  • 切片检查
  • 其他的

6. 全球甲状腺癌诊断市场：按最终用途分類的业务分析

  • 按最终用户分類的仪表板
  • 甲状腺癌诊断市场：依最终用途分類的差异分析
  • 全球甲状腺癌诊断市场规模及趋势分析（按最终用途划分）（2021-2033 年）
  • 医院检查室
  • 癌症诊断中心
  • 研究所
  • 其他的

第七章 全球甲状腺癌诊断市场：区域估算与趋势分析

  • 市场概览：按地区
  • 按地区分類的市场份额分析（2024 年和 2033 年）
  • 甲状腺癌诊断市场：关键点（按地区划分）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业热力图分析（2024 年）
  • 公司简介
    • Abbott
    • F.Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories, Inc.
    • GE HealthCare
    • Hologic, Inc.
    • Koninklijke Philips NV
    • Toshiba Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: GVR-4-68038-615-8

Thyroid Cancer Diagnostics Market Summary

The global thyroid cancer diagnostics market size was estimated at USD 3.07 billion in 2024 and is projected to reach USD 5.03 billion by 2033, growing at a CAGR of 5.86% from 2025 to 2033. This growth is attributed to the growing incidence of thyroid cancer, growing awareness of early screening programs, and significant technological advancements in diagnostic tools such as imaging modalities and molecular testing.

In addition, increased healthcare spending, favorable reimbursement policies, and a shift toward personalized medicine. Furthermore, the growing aging population, improved healthcare infrastructure, and ongoing research and development efforts further support market expansion, enabling earlier and more accurate detection and management of thyroid cancer.

Thyroid cancer diagnostics encompass a broad range of tests and procedures, including imaging, biopsies, blood tests, and molecular profiling used to detect and characterize thyroid cancer, guiding clinical decisions and personalized treatment. The global market for these diagnostics is expanding rapidly, largely due to the increasing number of thyroid cancer patients. This rise in cases has heightened the demand for early detection and effective screening tools, as healthcare providers prioritize proactive identification to improve outcomes. According to the American Cancer Society, about 44,020 new cases of thyroid cancer are expected to be diagnosed in the U.S. in 2025. Approximately 31,350 cases occur in women and 12,670 in men. Thyroid cancer is notably more common in women and is often diagnosed at a younger age compared to many other cancers.

A significant driver of this market is technological advancement. For instance, in May 2024, GE Healthcare introduced Revolution RT, an advanced radiation therapy computed tomography (CT) solution. This innovative system is designed to enhance imaging accuracy and streamline simulation workflows, supporting a more personalized and seamless oncology care experience. Revolution RT incorporates AI-driven technologies and updated software platforms, enabling clinicians to achieve precise tumor targeting and more efficient care pathways.

In addition, the adoption of telemedicine and digital health platforms has further expanded access to thyroid cancer diagnostics, especially for individuals in remote or underserved areas. Through virtual consultations, patients can receive early screening recommendations and follow-up care, ensuring timely intervention regardless of geographic barriers.

Moreover, the growing prevalence of genetic testing for hereditary risk factors is creating new opportunities in the market. Advanced genomic panels can identify mutations linked to thyroid tumors, aiding in more accurate diagnosis and personalized treatment strategies. Collectively, these factors, including the rising incidence of thyroid cancer, cutting-edge technology like Revolution RT, the shift toward personalized medicine, digital health accessibility, and expanded genetic testing, are driving robust growth in the thyroid cancer diagnostics industry, leading to earlier detection and improved patient care.

Global Thyroid Cancer Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global thyroid cancer diagnostics market report based on cancer type, technique, end use, and region.

  • Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Papillary carcinoma
  • Follicular carcinoma
  • Others
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Test
  • Imaging
  • Biopsy
  • Others
  • End Use Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Laboratories
  • Cancer Diagnostic Centers
  • Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Cancer Type
    • 1.2.2. Technique
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Cancer Type Outlook
    • 2.2.2. Technique Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thyroid Cancer Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Thyroid Cancer Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Thyroid Cancer Diagnostics Market: Cancer Type Business Analysis

  • 4.1. Cancer Type Segment Dashboard
  • 4.2. Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • 4.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Cancer Type, 2021 to 2033 (USD Million)
  • 4.4. Papillary carcinoma
    • 4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 4.5. Follicular carcinoma
    • 4.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Thyroid Cancer Diagnostics Market: Technique Business Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • 5.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Technique, 2021 to 2033 (USD Million)
  • 5.4. Blood Test
    • 5.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.5. Imaging
    • 5.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.6. Biopsy
    • 5.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Thyroid Cancer Diagnostics Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • 6.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospital Laboratories
    • 6.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.5. Cancer Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Global Thyroid Cancer Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. Global Thyroid Cancer Diagnostics Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F.Hoffmann-La Roche Ltd.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Siemens Healthcare GmbH
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GE HealthCare
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Hologic, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Toshiba Corporation
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Agilent Technologies, Inc.
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Illumina, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 3 Global Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 4 Global Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 5 Global Thyroid Cancer Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 6 North America Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 7 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 8 North America Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 9 North America Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 11 U.S Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 12 U.S Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 14 Canada Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 15 Canada Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 18 Mexico Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 21 Europe Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 22 Europe Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 24 Germany Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 25 Germany Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 UK Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 27 UK Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 28 UK Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 France Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 30 France Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 31 France Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 33 Italy Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 34 Italy Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 36 Spain Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 37 Spain Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 40 Denmark Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 43 Sweden Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 45 Norway Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 46 Norway Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 China Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 52 China Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 53 China Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 55 Japan Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 56 Japan Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 India Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 58 India Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 59 India Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 62 South Korea Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 64 Australia Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 65 Australia Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 67 Thailand Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 68 Thailand Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Thyroid Cancer Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 71 Latin America Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 72 Latin America Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 74 Brazil Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 75 Argentina Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 76 Argentina Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 77 Argentina Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 78 MEA Thyroid Cancer Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 79 MEA Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 80 MEA Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 81 MEA Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 South Africa Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 84 South Africa Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 UAE Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 89 UAE Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 90 UAE Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Thyroid Cancer Diagnostics Market, By Cancer Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Thyroid Cancer Diagnostics Market: Market Outlook
  • Fig. 10 Thyroid Cancer Diagnostics Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Thyroid Cancer Diagnostics Market Driver Impact
  • Fig. 16 Thyroid Cancer Diagnostics Market Restraint Impact
  • Fig. 17 Thyroid Cancer Diagnostics Market Strategic Initiatives Analysis
  • Fig. 18 Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • Fig. 19 Thyroid Cancer Diagnostics Market: Cancer Type Outlook and Key Takeaways
  • Fig. 20 Papillary Carcinoma Market Estimates and Forecast, 2021 - 2033
  • Fig. 21 Follicular Carcinoma Market Estimates and Forecast, 2021 - 2033
  • Fig. 22 Others Market Estimates and Forecast, 2021 - 2033
  • Fig. 23 Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • Fig. 24 Thyroid Cancer Diagnostics Market: Technique Outlook and Key Takeaways
  • Fig. 25 Blood Test Market Estimates and Forecast, 2021 - 2033
  • Fig. 26 Imaging Market Estimates and Forecast, 2021 - 2033
  • Fig. 27 Biopsy Market Estimates and Forecast, 2021 - 2033
  • Fig. 28 Others Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 30 Thyroid Cancer Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 31 Hospital Laboratories Market Estimates and Forecasts, 2021 - 2033
  • Fig. 32 Cancer Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033
  • Fig. 33 Research Institutes Market Estimates and Forecasts, 2021 - 2033
  • Fig. 34 Others Market Estimates and Forecasts, 2021 - 2033
  • Fig. 35 Global Thyroid Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 36 Global Thyroid Cancer Diagnostics Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 38 U.S Market Estimates and Forecasts, 2021 - 2033
  • Fig. 39 Canada Market Estimates and Forecasts, 2021 - 2033
  • Fig. 40 Mexico Market Estimates and Forecasts, 2021 - 2033
  • Fig. 41 Europe Market Estimates and Forecasts, 2021 - 2033
  • Fig. 42 UK Market Estimates and Forecasts, 2021 - 2033
  • Fig. 43 Germany Market Estimates and Forecasts, 2021 - 2033
  • Fig. 44 France Market Estimates and Forecasts, 2021 - 2033
  • Fig. 45 Italy Market Estimates and Forecasts, 2021 - 2033
  • Fig. 46 Spain Market Estimates and Forecasts, 2021 - 2033
  • Fig. 47 Denmark Market Estimates and Forecasts, 2021 - 2033
  • Fig. 48 Sweden Market Estimates and Forecasts, 2021 - 2033
  • Fig. 49 Norway Market Estimates and Forecasts, 2021 - 2033
  • Fig. 50 Asia Pacific Market Estimates and Forecasts, 2021 - 2033
  • Fig. 51 China Market Estimates and Forecasts, 2021 - 2033
  • Fig. 52 Japan Market Estimates and Forecasts, 2021 - 2033
  • Fig. 53 India Market Estimates and Forecasts, 2021 - 2033
  • Fig. 54 Thailand Market Estimates and Forecasts, 2021 - 2033
  • Fig. 55 South Korea Market Estimates and Forecasts, 2021 - 2033
  • Fig. 56 Australia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 57 Latin America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 58 Brazil Market Estimates and Forecasts, 2021 - 2033
  • Fig. 59 Argentina Market Estimates and Forecasts, 2021 - 2033
  • Fig. 60 Middle East and Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 61 South Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 62 Saudi Arabia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 63 UAE Market Estimates and Forecasts, 2021 - 2033
  • Fig. 64 Kuwait Market Estimates and Forecasts, 2021 - 2033